More than 115 million Americans live with prediabetes, a condition that often sits quietly in the background until it becomes type 2 diabetes. For years, researchers have asked whether a simple, widely available nutrient like vitamin D could help slow that shift.
The answer has not been straightforward. A major clinical trial testing high-dose vitamin D did not find a clear benefit for everyone with prediabetes. But a new analysis suggests the story may depend on something more personal.
Image Credit: mama_mia via Shutterstock
Why a broad vitamin D trial left an unanswered question
The new study, published in JAMA Network Open, looked back at data from the D2d study, a large clinical trial involving more than 2,000 U.S. adults with prediabetes. Participants took either 4,000 IU of vitamin D per day or a placebo to see whether the supplement could reduce their risk of developing diabetes.
Across the full group, the original trial did not show a significant reduction in diabetes risk. That could have ended the discussion. Instead, researchers wanted to know whether vitamin D might still help certain people more than others.
"But the D2d results raised an important question: Could vitamin D still benefit some people?" said Bess Dawson-Hughes, the study’s lead author and a senior scientist at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.
That question matters because diabetes can bring serious health problems that build gradually over time. Dawson-Hughes said that delaying the period a person lives with diabetes could help prevent some harmful effects or reduce their severity.
The genetic clue researchers followed
Vitamin D does not act alone in the body. It circulates in the blood, is converted into an active form, and then binds to the vitamin D receptor, a protein that helps cells respond to the vitamin.
Researchers focused on that receptor because genetic differences could help explain why some people appear to respond to vitamin D while others do not. The pancreas’s insulin-producing cells have vitamin D receptors, which suggests vitamin D may play a role in insulin release and blood sugar control.
For the new analysis, Dawson-Hughes and her colleagues studied genetic data from 2,098 participants who had agreed to DNA testing. They compared people who seemed to benefit from vitamin D with those who did not, then sorted participants by three common variations in the vitamin D receptor gene.
The key difference appeared in a variation called ApaI. Adults with the AA version, about 30% of the study population, did not respond to high-dose vitamin D compared with placebo. But adults with the AC or CC versions had a significantly lower risk of developing diabetes when taking high-dose vitamin D.
Overall, prediabetic adults with certain vitamin D receptor gene variations had a 19% lower risk of developing diabetes while taking the daily high dose.
What this could mean for prevention, and what it does not mean yet
The findings point toward a future where diabetes prevention could be more tailored to the individual. Rather than assuming vitamin D works the same way for everyone, doctors may someday be able to identify which patients with prediabetes are most likely to benefit.
"The findings may represent an important step toward developing a personalized approach to lowering the risk of developing type 2 diabetes among high-risk adults," said Anastassios Pittas, the study’s senior author, a professor of medicine at Tufts University School of Medicine, and chief of endocrinology, diabetes, and metabolism at Tufts Medical Center.
Pittas said vitamin D is appealing as a possible preventive tool because it is inexpensive, widely available, and easy to take.
Still, the researchers warned that people should not begin taking high doses of vitamin D on their own to prevent diabetes. Current guidelines recommend 600 IU per day for people ages 1 to 70 and 800 IU per day for those older than 70. Too much vitamin D can be harmful and has been linked to a higher risk of falls and fractures in older adults.
Dawson-Hughes said the findings suggest it may eventually be possible to identify people with prediabetes who are most likely to benefit from additional vitamin D supplementation, potentially through a single, relatively inexpensive genetic test.
For now, the main takeaway is not that vitamin D is a universal answer for prediabetes. It is that prevention may become more precise, with a person’s genes helping reveal which simple tools are most likely to help.
If you are interested in more details about the underlying research, be sure to check out the paper published in JAMA Network Open, listed below this article.
Sources, further reading and more interesting articles:
Can Taking Vitamin D Help Reduce the Risk of Dementia? - (Universal-Sci)
What is the best way to cook vegetables for maximum nutritional value? - (Universal-Sci)
Are you getting enough vitamin B1 to help fend off Alzheimer’s? - (Universal-Sci)
Vitamin D Receptor Polymorphisms and the Effect of Vitamin D Supplementation on Diabetes Risk Among Adults With Prediabetes - (JAMA Network Open)
Too busy to follow science news during the week? - Consider subscribing to our (free) newsletter - (Universal-Sci Weekly) - and get the 5 most interesting science articles of the week in your inbox
FEATURED ARTICLES:
